We are live on ! Find out more
AVXL icon

Anavex Life Sciences

108 hedge funds and large institutions have $272M invested in Anavex Life Sciences in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

260% more capital invested

Capital invested by funds: $75.6M → $272M (+$196M)

94% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 16

71% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 24

47% more call options, than puts

Call options by funds: $12.4M | Put options by funds: $8.46M

16% more funds holding

Funds holding: 93108 (+15)

5.34% more ownership

Funds ownership: 20.89%26.23% (+5.3%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
108
Holders Change
+15
Holders Change %
+16.13%
% of All Funds
1.9%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
31
Increased
41
Reduced
24
Closed
16
Calls
$12.4M
Puts
$8.46M
Net Calls
+$3.97M
Net Calls Change
+$5.02M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$65.7M +$7.85M +718,802 +20%
Vanguard Group
2
Vanguard Group
Pennsylvania
$50.7M +$5.43M +496,767 +17%
State Street
3
State Street
Massachusetts
$41.1M +$20.5M +1,872,614 +214%
Invesco
4
Invesco
Georgia
$16.8M +$9.84M +900,652 +401%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$15.5M +$2.64M +242,093 +31%
GLA
6
Great Lakes Advisors
Illinois
$10.3M +$7.52M +688,892 New
Northern Trust
7
Northern Trust
Illinois
$9.77M -$623 -57 -0%
Russell Investments Group
8
Russell Investments Group
United Kingdom
$3.86M -$941K -86,162 -25%
N
9
Nuveen
North Carolina
$3.76M +$545K +49,915 +25%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$3.06M +$118K +10,772 +6%
First Trust Advisors
11
First Trust Advisors
Illinois
$2.73M +$406K +37,164 +26%
Citigroup
12
Citigroup
New York
$2.69M +$1.86M +169,924 +1,687%
MWNA
13
Marshall Wace North America
New York
$2.68M +$1.96M +179,185 New
Bank of America
14
Bank of America
North Carolina
$2.67M +$1.75M +160,689 +908%
Marshall Wace
15
Marshall Wace
United Kingdom
$2.44M +$1.78M +163,087 New
Charles Schwab
16
Charles Schwab
California
$2.22M +$155K +14,189 +11%
Goldman Sachs
17
Goldman Sachs
New York
$2.03M +$1.11M +101,457 +295%
Rafferty Asset Management
18
Rafferty Asset Management
New York
$1.78M +$1.3M +118,977 New
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$1.6M -$106K -9,745 -8%
State of Wisconsin Investment Board
20
State of Wisconsin Investment Board
Wisconsin
$1.41M -$435K -39,800 -30%
Ameriprise
21
Ameriprise
Minnesota
$1.39M +$270K +24,725 +36%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$1.32M +$98.9K +9,055 +11%
Barclays
23
Barclays
United Kingdom
$1.3M +$147K +13,427 +18%
HP
24
Hikari Power
Japan
$1.28M
Morgan Stanley
25
Morgan Stanley
New York
$1.28M +$21K +1,926 +2%

AVXL Hedge Fund Activity: Q1 2021 in Review

108 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2021, worth a combined $272M — up 260% from $75.6M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new AVXL positions and 16 closed out — a net gain of 15 holders — while 41 added to existing stakes and 24 trimmed.

The largest buyer was State Street, adding an estimated $20.5M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $4.21M sold.

  • 108 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2021, up from 93 in Q4 2020.
  • Funds reported $272M of Anavex Life Sciences stock for Q1 2021, up 260% quarter-over-quarter.
  • 31 funds opened new Anavex Life Sciences positions in Q1 2021 and 16 closed out, a net change of +15 holders.
  • The largest Anavex Life Sciences buyer in Q1 2021 was State Street, an estimated $20.5M added.
  • The largest Anavex Life Sciences seller in Q1 2021 was Perceptive Advisors, an estimated $4.21M sold.

Based on aggregated 13F filings for Q1 2021.